EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.3600
+0.0100 (2.86%)
Oct 9, 2026, 4:10 PM AEST
EZZ Life Science Holdings Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -5.32 | 6.73 | 6.96 | 3.63 | 1.31 |
Depreciation & Amortization | 0.49 | 0.51 | 0.39 | 0.18 | 0.12 |
Stock-Based Compensation | 2.68 | 1.9 | 0.02 | 0.18 | 0.16 |
Other Operating Activities | 0.44 | -0.2 | -0.07 | -0.22 | - |
Change in Accounts Receivable | -0.4 | -1.84 | -1.29 | 0.91 | -0.11 |
Change in Inventory | -1.59 | -1.03 | -0.55 | -0.53 | -0.04 |
Change in Accounts Payable | -0.74 | 1.11 | 0.59 | -0.22 | 0.78 |
Change in Income Taxes | -2.94 | 0.31 | 0.86 | 0.05 | 0.06 |
Change in Other Net Operating Assets | -0.54 | -3.23 | -0.84 | -0.02 | -0.48 |
Operating Cash Flow | -8.76 | 4.37 | 6.14 | 4.01 | 1.9 |
Operating Cash Flow Growth | - | -28.87% | 53.05% | 111.08% | 650.09% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.03 | -0.24 | -0.41 | -0.1 | -0.01 |
Sale (Purchase) of Intangibles | -0 | -0.02 | -0.03 | - | -0.01 |
Other Investing Activities | -0.62 | -0.29 | - | - | - |
Investing Cash Flow | -0.65 | -0.55 | -0.44 | -0.1 | -0.01 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | -0.36 | -0.35 | -0.35 | -0.16 | -0.1 |
Lease Payments | -0.36 | -0.35 | -0.35 | -0.16 | -0.1 |
Net Debt Issued (Repaid) | -0.36 | -0.35 | -0.35 | -0.16 | -0.1 |
Issuance of Common Stock | - | - | 0.85 | - | - |
Common Dividends Paid | -0.9 | -1.82 | -1.08 | -0.6 | -0.17 |
Financing Cash Flow | -1.26 | -2.17 | -0.58 | -0.76 | -0.28 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.44 | 0.19 | 0.07 | 0.22 | - |
Miscellaneous Cash Flow Adjustments | - | -0.02 | - | - | - |
Net Cash Flow | -11.13 | 1.83 | 5.19 | 3.37 | 1.61 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -8.79 | 4.13 | 5.73 | 3.91 | 1.9 |
Free Cash Flow Growth | - | -28.05% | 46.57% | 106.35% | 665.88% |
Free Cash Flow Margin | -19.00% | 5.67% | 8.63% | 10.53% | 12.62% |
Free Cash Flow Per Share | -0.19 | 0.09 | 0.13 | 0.09 | 0.04 |
Levered Free Cash Flow | -7.56 | 3.74 | 4.61 | 4.06 | 1.61 |
Unlevered Free Cash Flow | -7.55 | 3.76 | 4.63 | 4.07 | 1.61 |
Free Cash Flow After Leases | -9.16 | 3.77 | 5.38 | 3.75 | 1.79 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.02 | 0.03 | 0.02 | 0.01 | 0 |
Cash Income Tax Paid | 2.7 | 3.45 | 2.07 | 1.17 | 0.31 |
Change in Working Capital | -7.05 | -4.58 | -1.16 | 0.24 | 0.31 |